Calcium 2-ethylhexanoate and 2-ethylhexyl-2-ethylhexanoate

These substances were identified for action under the Chemicals Management Plan (CMP).

Summary of publications
CAS RN Common name DSL name Proposed Order and RIAS Final screening assessment Proposed risk management approach Conclusion on section 64 criteria Follow-up activities
136-51-6 Calcium 2-ethylhexanoate Hexanoic acid, 2-ethyl-, calcium salt None HTML None Does not meet Significant New Activity (SNAc) provisions
7425-14-1 2-Ethylhexyl-2-ethylhexanoate Hexanoic acid, 2-ethyl-, 2-ethylhexyl ester HTML HTML Meets one or more of the criteria Refer to proposed risk management approach

Follow-up activities

While calcium 2-ethylhexanoate is not considered to be harmful to human health at levels of exposure considered in the assessment, it is considered to have a health effect of concern due to its potential developmental toxicity. Therefore, there may be a potential concern if exposures were to increase. As such, the SNAc provisions of the Canadian Environmental Protection Act, 1999 (CEPA 1999) have been applied to calcium 2-ethylhexanoate.

Timelines
Date Activity
August 17, 2022 Publication in the Canada Gazette, Part II: Vol. 156, No. 17 of an order amending the Domestic Substances List (DSL) to apply the SNAc provisions of CEPA 1999 to calcium 2-ethylhexanoate.
September 12, 2020 Publication in the Canada Gazette, Part I: Vol. 154, No. 37 of a notice of intent to amend the DSL to apply the SNAc provisions of CEPA 1999 to 2-ethylhexyl-2-ethylhexanoate and start of 60-day public comment period.
March 2, 2019 Publication in the Canada Gazette, Part I: Vol. 153, No. 9 of a proposed order adding 2-ethylhexyl-2-ethylhexanoate to Schedule 1 of CEPA 1999 and start of 60-day public comment period.
December 15, 2018 Publication of the Final Screening Assessment for Calcium 2-Ethylhexanoate and 2-Ethylhexyl-2-ethylhexanoate. The Risk Management Approach for 2-Ethylhexyl-2-ethylhexanoate was also published for a 60-day public comment period. The related notice was published in the Canada Gazette, Part I: Vol. 152, No. 50.
December 15, 2018 Publication in the Canada Gazette, Part I: Vol. 152, No. 50 of a notice of intent to amend the DSL to apply the SNAc provisions of CEPA 1999 to calcium 2-ethylhexanoate and start of 60-day public comment period.
March 25, 2017 Publication and start of 60-day public comment period on the Draft Screening Assessment for Calcium 2-Ethylhexanoate and 2-Ethylhexyl-2-ethylhexanoate (including follow-up activities for calcium 2-ethylhexanoate) and the Risk Management Scope for 2-Ethylhexyl-2-ethylhexanoate. The related notice was published in the Canada Gazette, Part I: Vol. 151, No. 12.

Page details

Date modified: